The malate–aspartate shuttle in gastric atrophy and precancerous progression: an emerging redox–bioenergetic axis
Abstract
Gastric atrophy is a precursor of intestinal-type gastric cancer and is associated with mitochondrial and metabolic abnormalities. The malate–aspartate shuttle (MAS) couples cytosolic NADH oxidation to mitochondrial metabolism and intersects with glycolysis, the tricarboxylic acid cycle, aspartate metabolism, and biosynthesis. This review distinguishes direct gastric observations from mechanistic evidence obtained in other systems. Gastric studies report heterogeneous mitochondrial, metabolite, and component-level findings in different histological and etiological settings. Prospective tissue and plasma omics studies identify progression-associated signatures, but do not establish a longitudinal MAS trajectory, and integrated shuttle function remains unresolved in gastric atrophy and intestinal metaplasia. We consider three context-dependent interpretations: secondary remodeling, a maladaptive contribution to injury, and protective adaptation. These roles may coexist or change over time rather than form mutually exclusive categories. Distinguishing them requires defined baseline functional changes, bidirectional perturbations under matched upstream stress, compartment-resolved redox measurements, and complementary enzyme/carrier interventions linked to gastric phenotypes. Reconstituted shuttle activity must also be distinguished from endogenous flux in intact cells. The MAS provides a hypothesis-generating framework for gastric redox–bioenergetic research; its disease-stage behavior, causal significance, and therapeutic direction require direct validation.
Related
- Emerging roles and mechanistic insights of ASRGL1 in tumorigenesis and cancer progression
- Translated Circular RNAs in Glioblastoma: Emerging Regulators of Tumor Progression, Molecular Heterogeneity and Therapeutic Resistance
- Novel Shuttle Markers for Nuclear Transformation of the Green Alga Chlamydomonas reinhardtii
- A Combination of Ursolic Acid and Oleanolic Acid Disrupts Bioenergetic Homeostasis in Prostate Cancer and Inhibits Cancer Growth by Cytotoxic Autophagy
- Redox-dependent remodeling of mitochondrial nucleoids contributes to bioenergetic decline during neuronal aging
BibTeX
@article{yang2026malateaspartate,
title = {{The malate–aspartate shuttle in gastric atrophy and precancerous progression: an emerging redox–bioenergetic axis}},
author = {Liu Yang and Zixin Pang and Bolin Li and Chenxi Yan and Hongxia Wang and Zhiyao Liu and Shaopo Wang and Diangui Li and Qian Yang},
journal = {Frontiers in Molecular Biosciences},
year = {2026},
month = nov,
doi = {10.3389/fmolb.2026.2000435},
url = {https://www.frontiersin.org/articles/10.3389/fmolb.2026.2000435},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The malate–aspartate shuttle in gastric atrophy and precancerous progression: an emerging redox–bioenergetic axis
AU - Liu Yang
AU - Zixin Pang
AU - Bolin Li
AU - Chenxi Yan
AU - Hongxia Wang
AU - Zhiyao Liu
AU - Shaopo Wang
AU - Diangui Li
AU - Qian Yang
PY - 2026
DA - 2026/11/05
JO - Frontiers in Molecular Biosciences
DO - 10.3389/fmolb.2026.2000435
UR - https://www.frontiersin.org/articles/10.3389/fmolb.2026.2000435
AB - Gastric atrophy is a precursor of intestinal-type gastric cancer and is associated with mitochondrial and metabolic abnormalities. The malate–aspartate shuttle (MAS) couples cytosolic NADH oxidation to mitochondrial metabolism and intersects with glycolysis, the tricarboxylic acid cycle, aspartate metabolism, and biosynthesis. This review distinguishes direct gastric observations from mechanistic evidence obtained in other systems. Gastric studies report heterogeneous mitochondrial, metabolite, and component-level findings in different histological and etiological settings. Prospective tissue and plasma omics studies identify progression-associated signatures, but do not establish a longitudinal MAS trajectory, and integrated shuttle function remains unresolved in gastric atrophy and intestinal metaplasia. We consider three context-dependent interpretations: secondary remodeling, a maladaptive contribution to injury, and protective adaptation. These roles may coexist or change over time rather than form mutually exclusive categories. Distinguishing them requires defined baseline functional changes, bidirectional perturbations under matched upstream stress, compartment-resolved redox measurements, and complementary enzyme/carrier interventions linked to gastric phenotypes. Reconstituted shuttle activity must also be distinguished from endogenous flux in intact cells. The MAS provides a hypothesis-generating framework for gastric redox–bioenergetic research; its disease-stage behavior, causal significance, and therapeutic direction require direct validation.
SN - 2296-889X
ER -